1. Home
  2. VERA vs PII Comparison

VERA vs PII Comparison

Compare VERA & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • PII
  • Stock Information
  • Founded
  • VERA 2016
  • PII 1954
  • Country
  • VERA United States
  • PII United States
  • Employees
  • VERA N/A
  • PII N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • PII Recreational Games/Products/Toys
  • Sector
  • VERA Health Care
  • PII Consumer Discretionary
  • Exchange
  • VERA Nasdaq
  • PII Nasdaq
  • Market Cap
  • VERA 2.0B
  • PII 1.9B
  • IPO Year
  • VERA 2021
  • PII 1987
  • Fundamental
  • Price
  • VERA $20.86
  • PII $39.29
  • Analyst Decision
  • VERA Buy
  • PII Hold
  • Analyst Count
  • VERA 8
  • PII 12
  • Target Price
  • VERA $64.63
  • PII $41.40
  • AVG Volume (30 Days)
  • VERA 2.9M
  • PII 1.3M
  • Earning Date
  • VERA 08-07-2025
  • PII 07-22-2025
  • Dividend Yield
  • VERA N/A
  • PII 6.82%
  • EPS Growth
  • VERA N/A
  • PII N/A
  • EPS
  • VERA N/A
  • PII 0.71
  • Revenue
  • VERA N/A
  • PII $7,072,600,000.00
  • Revenue This Year
  • VERA N/A
  • PII N/A
  • Revenue Next Year
  • VERA N/A
  • PII $3.92
  • P/E Ratio
  • VERA N/A
  • PII $55.46
  • Revenue Growth
  • VERA N/A
  • PII N/A
  • 52 Week Low
  • VERA $18.53
  • PII $30.92
  • 52 Week High
  • VERA $51.61
  • PII $88.00
  • Technical
  • Relative Strength Index (RSI)
  • VERA 43.65
  • PII 47.72
  • Support Level
  • VERA $20.37
  • PII $39.76
  • Resistance Level
  • VERA $23.14
  • PII $43.51
  • Average True Range (ATR)
  • VERA 1.70
  • PII 1.56
  • MACD
  • VERA -0.46
  • PII -0.29
  • Stochastic Oscillator
  • VERA 3.88
  • PII 37.76

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

Share on Social Networks: